Induction of COX-2 and reactive gliosis by P2Y receptors in rat cortical astrocytes is dependent on ERK1/2 but independent of calcium signalling

Roberta Brambilla, Joseph T. Neary, Flaminio Cattabeni, Lorenzo Cottini, Gianluca D'Ippolito, Paul C Schiller, Maria P. Abbracchio

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

The present study has been aimed at characterizing the ATP/ P2 receptor (and transductional pathways) responsible for the morphological changes induced in vitro by αβmethyleneATP on rat astrocytes obtained from cerebral cortex, a brain area highly involved in neurodegenerative diseases. Exposure of cells to this purine analogue resulted in elongation of cellular processes, an event reproducing in vitro a major hallmark of in vivo reactive gliosis. αβmethyleneATP-induced gliosis was prevented by the P2X/P2Y blocker pyridoxalphosphate-6-azophenyl-2′-4′-disulfonic acid, but not by the selective P2X antagonist 2′,3′-O-(2,4,6-trinitrophenyl)-ATP, ruling out a role for ligand-gated P2X receptors. Conversely, the Gi/Go protein inactivator pertussis toxin completely prevented αβmethyleneATP-induced effects. No effects were induced by αβmethyleneATP on intracellular calcium concentrations. RT-PCR and western blot analysis showed that αβmethyleneATP-induced gliosis involves up-regulation of cyclooxygenase-2 (but not lipooxygenase). Also this effect was fully prevented by pyridoxalphosphate-6-azophenyl-2′-4′-disulfonic acid. Experiments with inhibitors of mitogen-activated protein kinases (MAPK) suggest that extracellular signal regulated protein kinases (ERK)1/2 mediate both cyclooxygenase-2 induction and the associated in vitro gliosis. These findings suggest that purine-induced gliosis involves the activation of a calcium-independent G-protein-coupled P2Y receptor linked to ERK1/2 and cyclooxygenase-2. Based on the involvement of cyclooxygenase-2 and inflammation in neurodegenerative diseases, these findings open up new avenues in the identification of novel biological targets for the pharmacological manipulation of neurodegeneration.

Original languageEnglish
Pages (from-to)1285-1296
Number of pages12
JournalJournal of Neurochemistry
Volume83
Issue number6
DOIs
StatePublished - Dec 1 2002

Fingerprint

Gliosis
Calcium Signaling
Cyclooxygenase 2
Astrocytes
Rats
Neurodegenerative diseases
Calcium
Adenosine Triphosphate
Neurodegenerative Diseases
Acids
Pertussis Toxin
Purinergic P2 Receptors
Mitogen-Activated Protein Kinases
GTP-Binding Proteins
Protein Kinases
Extracellular Signal-Regulated MAP Kinases
Elongation
Brain
G-Protein-Coupled Receptors
Cerebral Cortex

Keywords

  • Cyclooxygenase-2
  • Neurodegenerative diseases
  • Neuroinflammation
  • P2Y receptors
  • Rat cortex
  • Reactive astrogliosis

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Induction of COX-2 and reactive gliosis by P2Y receptors in rat cortical astrocytes is dependent on ERK1/2 but independent of calcium signalling. / Brambilla, Roberta; Neary, Joseph T.; Cattabeni, Flaminio; Cottini, Lorenzo; D'Ippolito, Gianluca; Schiller, Paul C; Abbracchio, Maria P.

In: Journal of Neurochemistry, Vol. 83, No. 6, 01.12.2002, p. 1285-1296.

Research output: Contribution to journalArticle

Brambilla, Roberta ; Neary, Joseph T. ; Cattabeni, Flaminio ; Cottini, Lorenzo ; D'Ippolito, Gianluca ; Schiller, Paul C ; Abbracchio, Maria P. / Induction of COX-2 and reactive gliosis by P2Y receptors in rat cortical astrocytes is dependent on ERK1/2 but independent of calcium signalling. In: Journal of Neurochemistry. 2002 ; Vol. 83, No. 6. pp. 1285-1296.
@article{b9f67edcac12446e9250aad36940a29a,
title = "Induction of COX-2 and reactive gliosis by P2Y receptors in rat cortical astrocytes is dependent on ERK1/2 but independent of calcium signalling",
abstract = "The present study has been aimed at characterizing the ATP/ P2 receptor (and transductional pathways) responsible for the morphological changes induced in vitro by αβmethyleneATP on rat astrocytes obtained from cerebral cortex, a brain area highly involved in neurodegenerative diseases. Exposure of cells to this purine analogue resulted in elongation of cellular processes, an event reproducing in vitro a major hallmark of in vivo reactive gliosis. αβmethyleneATP-induced gliosis was prevented by the P2X/P2Y blocker pyridoxalphosphate-6-azophenyl-2′-4′-disulfonic acid, but not by the selective P2X antagonist 2′,3′-O-(2,4,6-trinitrophenyl)-ATP, ruling out a role for ligand-gated P2X receptors. Conversely, the Gi/Go protein inactivator pertussis toxin completely prevented αβmethyleneATP-induced effects. No effects were induced by αβmethyleneATP on intracellular calcium concentrations. RT-PCR and western blot analysis showed that αβmethyleneATP-induced gliosis involves up-regulation of cyclooxygenase-2 (but not lipooxygenase). Also this effect was fully prevented by pyridoxalphosphate-6-azophenyl-2′-4′-disulfonic acid. Experiments with inhibitors of mitogen-activated protein kinases (MAPK) suggest that extracellular signal regulated protein kinases (ERK)1/2 mediate both cyclooxygenase-2 induction and the associated in vitro gliosis. These findings suggest that purine-induced gliosis involves the activation of a calcium-independent G-protein-coupled P2Y receptor linked to ERK1/2 and cyclooxygenase-2. Based on the involvement of cyclooxygenase-2 and inflammation in neurodegenerative diseases, these findings open up new avenues in the identification of novel biological targets for the pharmacological manipulation of neurodegeneration.",
keywords = "Cyclooxygenase-2, Neurodegenerative diseases, Neuroinflammation, P2Y receptors, Rat cortex, Reactive astrogliosis",
author = "Roberta Brambilla and Neary, {Joseph T.} and Flaminio Cattabeni and Lorenzo Cottini and Gianluca D'Ippolito and Schiller, {Paul C} and Abbracchio, {Maria P.}",
year = "2002",
month = "12",
day = "1",
doi = "10.1046/j.1471-4159.2002.01239.x",
language = "English",
volume = "83",
pages = "1285--1296",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "6",

}

TY - JOUR

T1 - Induction of COX-2 and reactive gliosis by P2Y receptors in rat cortical astrocytes is dependent on ERK1/2 but independent of calcium signalling

AU - Brambilla, Roberta

AU - Neary, Joseph T.

AU - Cattabeni, Flaminio

AU - Cottini, Lorenzo

AU - D'Ippolito, Gianluca

AU - Schiller, Paul C

AU - Abbracchio, Maria P.

PY - 2002/12/1

Y1 - 2002/12/1

N2 - The present study has been aimed at characterizing the ATP/ P2 receptor (and transductional pathways) responsible for the morphological changes induced in vitro by αβmethyleneATP on rat astrocytes obtained from cerebral cortex, a brain area highly involved in neurodegenerative diseases. Exposure of cells to this purine analogue resulted in elongation of cellular processes, an event reproducing in vitro a major hallmark of in vivo reactive gliosis. αβmethyleneATP-induced gliosis was prevented by the P2X/P2Y blocker pyridoxalphosphate-6-azophenyl-2′-4′-disulfonic acid, but not by the selective P2X antagonist 2′,3′-O-(2,4,6-trinitrophenyl)-ATP, ruling out a role for ligand-gated P2X receptors. Conversely, the Gi/Go protein inactivator pertussis toxin completely prevented αβmethyleneATP-induced effects. No effects were induced by αβmethyleneATP on intracellular calcium concentrations. RT-PCR and western blot analysis showed that αβmethyleneATP-induced gliosis involves up-regulation of cyclooxygenase-2 (but not lipooxygenase). Also this effect was fully prevented by pyridoxalphosphate-6-azophenyl-2′-4′-disulfonic acid. Experiments with inhibitors of mitogen-activated protein kinases (MAPK) suggest that extracellular signal regulated protein kinases (ERK)1/2 mediate both cyclooxygenase-2 induction and the associated in vitro gliosis. These findings suggest that purine-induced gliosis involves the activation of a calcium-independent G-protein-coupled P2Y receptor linked to ERK1/2 and cyclooxygenase-2. Based on the involvement of cyclooxygenase-2 and inflammation in neurodegenerative diseases, these findings open up new avenues in the identification of novel biological targets for the pharmacological manipulation of neurodegeneration.

AB - The present study has been aimed at characterizing the ATP/ P2 receptor (and transductional pathways) responsible for the morphological changes induced in vitro by αβmethyleneATP on rat astrocytes obtained from cerebral cortex, a brain area highly involved in neurodegenerative diseases. Exposure of cells to this purine analogue resulted in elongation of cellular processes, an event reproducing in vitro a major hallmark of in vivo reactive gliosis. αβmethyleneATP-induced gliosis was prevented by the P2X/P2Y blocker pyridoxalphosphate-6-azophenyl-2′-4′-disulfonic acid, but not by the selective P2X antagonist 2′,3′-O-(2,4,6-trinitrophenyl)-ATP, ruling out a role for ligand-gated P2X receptors. Conversely, the Gi/Go protein inactivator pertussis toxin completely prevented αβmethyleneATP-induced effects. No effects were induced by αβmethyleneATP on intracellular calcium concentrations. RT-PCR and western blot analysis showed that αβmethyleneATP-induced gliosis involves up-regulation of cyclooxygenase-2 (but not lipooxygenase). Also this effect was fully prevented by pyridoxalphosphate-6-azophenyl-2′-4′-disulfonic acid. Experiments with inhibitors of mitogen-activated protein kinases (MAPK) suggest that extracellular signal regulated protein kinases (ERK)1/2 mediate both cyclooxygenase-2 induction and the associated in vitro gliosis. These findings suggest that purine-induced gliosis involves the activation of a calcium-independent G-protein-coupled P2Y receptor linked to ERK1/2 and cyclooxygenase-2. Based on the involvement of cyclooxygenase-2 and inflammation in neurodegenerative diseases, these findings open up new avenues in the identification of novel biological targets for the pharmacological manipulation of neurodegeneration.

KW - Cyclooxygenase-2

KW - Neurodegenerative diseases

KW - Neuroinflammation

KW - P2Y receptors

KW - Rat cortex

KW - Reactive astrogliosis

UR - http://www.scopus.com/inward/record.url?scp=18744383029&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18744383029&partnerID=8YFLogxK

U2 - 10.1046/j.1471-4159.2002.01239.x

DO - 10.1046/j.1471-4159.2002.01239.x

M3 - Article

C2 - 12472883

AN - SCOPUS:18744383029

VL - 83

SP - 1285

EP - 1296

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 6

ER -